How ANDA, NDA & DMF Are Reviewed: Step-by-Step Regulatory Overview скачать в хорошем качестве

How ANDA, NDA & DMF Are Reviewed: Step-by-Step Regulatory Overview

In this video, we discuss the complete review process of ANDA, NDA, and DMF as per USFDA regulatory framework. Understanding how regulatory submissions are evaluated is essential for professionals working in Regulatory Affairs, Quality Assurance, Quality Control, and Pharmaceutical Development. 🔎 In this session, you will learn: What happens after ANDA submission? NDA review pathway and timelines DMF review mechanism and deficiency letters Role of CMC, Bioequivalence, and labeling review Complete Response Letter (CRL) process Differences in ANDA vs NDA review Common regulatory observations How USFDA evaluates technical documents This video is highly useful for: ✔ B.Pharmacy & M.Pharmacy students ✔ Regulatory Affairs aspirants ✔ QA/QC professionals ✔ Interview preparation for pharma jobs If you are planning a career in Drug Regulatory Affairs, this video will give you conceptual clarity on the USFDA review workflow. Join this channel to get access to perks:    / @pharmatimesofficial